Document:

Exhibit 10.15

                               EMPLOYMENT CONTRACT
                          FOR AN INDETERMINATE DURATION

Concluded between the undersigned:

POLY IMPLANT  PROSTHESES  P.I.P.  S.A. with an  authorized  capital of 3,628,800
Euros, registered with the Toulon stock exchange under number B 382 473 254 91 B
640, whose social  security  premiums are paid to the URSSAF of Var under number
830 125  840,  represented  by the  president  of its  Board of  Directors,  Mr.
Jean-Claude MAS;

AND

Mr. Claude COUTY, born on February 8, 1952 at Janzac (17), of French
citizenship, bachelor, residing and domiciled at 74 Saint Blaise, 75020 Paris

Who have agreed to the following:

SECTION I - EMPLOYMENT

Mr. Claude Couty, who states not being bound under any other contract of
employment, is hereby hired as an administrative and financial director, subject
to the results of a medical examination.

The nominative statement preceding the hiring was made to the URSSAF of Toulon.
Pursuant to the Act dated January 6, 1978, Mr. Claude Couty has the right to
access and to correct the information on said document.

SECTION II - DURATION OF THE CONTRACT AND PROBATIONARY PERIOD

This contract is concluded for an indeterminate period starting on October 6,
2003.

It will only have full effect at the end of a probationary period of three
months, which will expire on January 5, 2004 and which may be renewed once.

Considering the nature and importance of the work to be accomplished by Mr.
Claude Couty, the parties acknowledge that they cannot be definitively bound by
this contract before the expiry of the probationary period. During this period,
each of the parties may cancel this contract, without any compensation, at any
time simply by sending a registered letter with a postal receipt.

>>       However, from the second month of actual employment, except in case of
         a serious fault, each of the parties must forward the following notice:
        -        of one week during the second month
        -        of two weeks during the third month.

>>       In case the probationary period should be renewed, and except in case
         of a serious fault, each one of the parties will be required to forward
         the following notice:
        -        three weeks from February 5, 2004;
        -        one month from March 5, 2004.

The contract may be terminated up to the last day of the period (the indemnity
for the advance notice that has not been respected will be paid by the party
terminating the contract).

It is specifically agreed that Mr. Claude Coty will not move before the end of
the probationary period and before this contract becomes binding. His moving
expenses will then be reimbursed to him on presentation of the invoice.

If Mr. Claude Couty decides to move during the probationary period, the expenses
for this and for his family's travelling expenses will be paid by himself. In
case the contract should be terminated during said period, the expenses for
moving and his family's return travelling expenses will be borne by Mr. Claude
Couty.

                                        2

<PAGE>

SECTION III - FUNCTIONS

Mr. Claude Couty, in close partnership with the president of the Company's Board
of Directors, will act as administrative and financial director, CFO,
specifically responsible for the internal control and financial management of
the Company, administrative management, human resources management, for
relations with national and international partners and for the financial audit
of the dealers distributing the company's products.

Because of his extensive knowledge and competency in corporate taxation law,
accounting, securities law and financial markets, Mr. Claude Couty will be
specifically responsible for the financial management of the Company (control of
management, financial management, consolidation, funding, investment follow up,
financial engineering, significant financial transactions and Company financial
communications) together with the persons responsible for accounts and Company
accountants.

Because of his level of responsibility, Mr. Claude Couty has wide discretion and
independence in decision-making. In order to perform his assignments, he will
have delegated signatures with the Company's banks and will be authorized to
sign checks and all types of instruments for payment up to a maximum limit of
150,000 Euros.
The Board of Directors and its President are liable to modify Mr. Claude Couty's
assignments and functions. Mr. Claude Couty will perform his work at the head
office of the P.I.P. Company, presently located at 337 Avenue de Bruxelles,
83507 La Seyne sur Mer, but also at any place where the company conducts its
activities.

In order to perform all his assignments, Mr. Claude Couty will be required to
travel outside of France, especially to perform his audit functions of the
companies distributing products manufactured by the P.I.P. Company.

SECTION IV - COMPENSATION AND DURATION OF WORK

As administrative and financial director, and considering the characteristics
and nature of the functions and responsibilities which he must assume, Mr.
Claude Couty will not be subject to a determined work schedule.

Accordingly, Mr. Claude Couty will have total freedom in organizing and managing
his time in order to perform his assignments.

In consideration of the performance of this work, Mr. Claude Couty will be paid
a gross annual salary of 106,715 Euros, or a gross monthly compensation of
8,892.91 Euros for twelve months. This is lump-sum compensation and has no
bearing on the actual time that Mr. Claude Couty spends in the performance of
his work.

The parties to this contract will meet each year from July 1st to examine the
compensation paid under this contract, considering:

-the economic context in which the Company operates,
-its financial results.

SECTION V - AVAILABILITY OF A MOTOR VEHICLE

The P.I.P. Company will assign to Mr. Claude Couty from the date he is hired, a
touring type motor vehicle developing a minimum of 5 horsepower.

The availability of a motor vehicle in the performance of his functions will be
governed by the 2/7 rule authorizing an employee to use it for personal
purposes.

The Company will pay maintenance expenses and insurance premiums and the gas
will be paid only for travelling for the purposes of employment.

In case of accident, within 48 hours Mr. Claude Couty must advise the Company as
well as the insurance company and give all the details of the accident. The
omission to respect this clause will entail Mr. Claude Couty's liability and the
Company may institute any recourse against him.

SECTION VI - LEAVE OF ABSENCE

Mr. Claude Couty must immediately advise the P.I.P. Company of any leave of
absence due to illness or accident. He must supply a medical certificate
explaining his absence within 48 hours.

                                        3

<PAGE>

In case of an extended leave of absence, Mr. Claude Couty must within the same
time limit, supply a medical certificate explaining such an extended leave.

SECTION VII - PAID HOLIDAYS

Mr. Claude Couty will be entitled to the paid holidays specified under sections
L 223-1 et seq. of the Labour Code.

SECTION VIII - CONFIDENTIALITY AND LOYALTY

Considering the nature of his functions, for the duration of this contract, Mr.
Claude Couty will not for any reason whatsoever become employed by any company
manufacturing or selling articles that may compete with those manufactured and
sold by the P.I.P. Company (especially companies manufacturing or selling highly
technical products which are manufactured by the Company, including mammary
implants, restraints, prostheses).

Mr. Claude Couty will not in any way disclose to anyone, plans, studies,
designs, projects, achievements prepared or performed by the Company, either for
its own clients or for itself and said Claude Couty will be bound by the most
absolute professional secrecy. The same thing applies to the information,
results, etc. stemming from the work performed in the Company or for its
clients.

This obligation of professional secrecy will continue to apply even after the
termination of this contract, no matter for what reason.

SECTION IX - BREACH OF THE CONTRACT OF EMPLOYMENT - COMPENSATION IN LIEU OF
NOTICE

Except in the case of serious misconduct on his behalf, Mr. Claude Couty will be
entitled in case of termination of this contract after a continuous duration of
service of at least one year for the company, to compensation in lieu of notice.

Such compensation is calculated for each year of continuous service for the
Company at 2/5 of the average monthly salary earned during the preceding year,
without taking into consideration participation or sales support bonuses.

In making the above calculation, fractions of years will be considered.

The compensation in lieu of notice specified herein is in lieu of the
compensation specified by law.

Such compensation will not be paid in case of retirement for which retirement
compensation will be paid according to the conditions specified by law.

In either one of the following cases:

        - termination negotiated following a layoff for economic reasons
          distinct from any restructuring or social plan;
        - termination negotiated with a change of majority shareholder of the
          Poly Implant Protheses Company or the holding company that controls
          it;

the gross compensation for a voluntary termination cannot be less than an amount
equivalent to 12 months of average monthly salary for more than one year of
seniority but equal to or less than two years. It cannot be less than an amount
equivalent to 36 months of average monthly salary for more than two years of
seniority.

The average monthly salary is the average salary paid during the twelve months
preceding termination, not taking into consideration participation and sales
support bonuses.

SECTION X - NON-COMPETITION

In case of the termination of this contract for any reason whatsoever,
considering the nature of his functions and his level of responsibility, Mr.
Claude Couty will not:

-accept employment with a competing company, especially (as the case may be)
which designs, manufactures or sells the following products: mammary prostheses,
restraints and derived products;

-get involved either directly or indirectly in the manufacture or sale of
products which may compete with those of the P.I.P. Company

                                        4

<PAGE>

This non-competition clause is restricted to a period of two years beginning on
the day of the actual termination of employment and covers the complete area of
France, considering the highly technical nature of the products manufactured by
the P.I.P. Company, the special knowledge required to manufacture these products
and the small number of companies liable to manufacture such products.

In consideration of the non-competition clause specified above, after the actual
termination of this contract and for the duration of this prohibition, Mr.
Claude Couty will be paid a special lump-sum indemnity equal to 50% of his
annual salary paid in the last year.

This indemnity will be paid on a monthly pro rata basis for the duration of the
period of non-competition as long as Mr. Claude Couty respects this obligation.

However, the P.I.P. Company may relieve Mr. Claude Couty from this obligation of
non-competition and be relieved of its own obligation of payment of the
indemnity at any time during the performance of the contract of employment or on
its termination. In case of termination, it must notify its decision by
registered letter sent at the latest on the day of the actual termination.

For any infringement of this non-competition clause, Mr. Claude Couty will be
automatically liable to pay a penalty established herein in an amount of 50,000
Euros, without the necessity of a letter of default advising said Claude Couty
to cease such competitive activities.

The payment of this indemnity will not prevent the Company from having the right
to claim from Mr. Claude Couty the damages sustained by it as well as obtaining
any type of court order, such as an injunction to end the competitive activity.

SECTION XI - VARIOUS PROVISIONS

The parties will abide by all legislative and regulatory provisions, as well as
those specified in any agreement in force within the Company and Mr. Claude
Couty declares having read the internal regulation.

In addition, Mr. Claude Couty declares not being bound by any agreement or by
any non-competition clause with a previous employer.

He will advise the P.I.P. Company of any change in his personal situation as
soon as possible.

Mr. Claude Couty will be covered by the social legislation that applies to
employees, specifically concerning social security and the additional pension
plan.

Mr. Claude Couty is a manager and as soon as he is hired by the Company, he will
be included in the following plans:

The CIRCACIC directors' retirement plan
The UGRR retirement plan
The staff CIPRA CAPICAF providence scheme (directors' scheme) The PRADO
PREALLIANCE mutual health program of directors at the end of his probationary
period.

The Company does not presently have a collective agreement (NAF 331 B). It is
governed by the Social Labour Code.

Concluded at Seyne sur Mer
On October 2, 2003

Mr. Claude Couty                              The CEO
                                              Mr. Jean-Claude Mas

Signatures are preceded by the handwritten words "Read and approved."

                                        5Amendment No.1 to Securities Purchase Agreement

 EXHIBIT 4.9 
  

AMENDMENT NO. 1 AND AGREEMENT 
  
 This AMENDMENT NO. 1 AND AGREEMENT, dated as of September 15, 2004, (this “Amendment No. 1”), by and between VERTICAL HEALTH SOLUTIONS,
INC., a Florida corporation (the “Parent”), VERTICAL HEALTH VENTURES, INC., a Delaware Corporation (the “Company”) and wholly owned subsidiary of the Parent and LAURUS MASTER FUND, LTD., a Cayman Islands company
(“Laurus”). 
  
 Reference is made to (i) the
Securities Purchase Agreement, dated as of May 27, 2004, among the Parent, the Company and Laurus (as amended, modified or supplemented from time to time, the “Securities Purchase Agreement”) and (ii) the By-Laws of the Company (as
amended, modified or supplemented from time to time, the “By-Laws”). Unless otherwise indicated, capitalized terms used herein without definition shall have the meanings ascribed to such terms in the Securities Purchase Agreement.

  
 NOW, THEREFORE, in consideration of the above, and for other
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows: 
  
 1. The reference to “$1.67” set forth in the first WHEREAS clause of the Securities Purchase Agreement is hereby deleted and the amount
“$0.65” is hereby is hereby inserted in lieu thereof. 
  
 2. Section 6.2 of the Securities Purchase Agreement is hereby deleted in its entirety and the following Section 6.2 is hereby inserted in lieu thereof: 
  

“6.2 Listing. The Company’s shares of Common Stock issuable upon conversion of the Series A Preferred and upon the exercise of the
Warrant are listed on the NASD OTCBB (together with such other market acceptable to the Purchaser, the “Principal Market”) as of the date hereof and, subject to the last sentence of this Section, the Company shall maintain such on a
Principal Market so long as any other shares of Common Stock shall be so listed. The Company will maintain the listing of its Common Stock on a Principal Market, and will comply in all material respects with the Company’s reporting, filing and
other obligations under the bylaws or rules of the National Association of Securities Dealers (“NASD”) and such exchanges, as applicable.” 
  
 3. The Company and Laurus hereby agree that Section 10.1 of the By-Laws may be amended to read in its entirety as follows: 
  
 “Section 10.1. Dissolution and Winding up of the
Corporation. The Corporation shall cease doing business and immediately dissolve, wind up its affairs and distribute its assets without further action on the part of the Board of Directors or the shareholders of the Corporation (to the fullest
extent permitted by the Certificate of 

 Incorporation consistent with General Corporation Law of the State of Delaware, as amended from time to time); upon the
occurrence of the following events (each of the following, an “Event of Default”): (i) the Parent shall no longer be listed on a Principal Market as defined below; (ii) the Parent shall fail to pay any dividend on the capital stock of
Corporation, and such failure to pay dividends shall occur twice within any six month period; (iii) the Parent shall not comply with a request from a holder of the preferred stock of the Corporation to convert such preferred stock into the
Parent’s common stock and such failure to convert such shares shall continue for twenty (20) days; (iv) the Parent shall fail to complete an effective registration statement registering shares of its common stock underlying (a) the conversion
of the Corporation’s preferred stock or (b) any warrants issued to holders of the Corporation’s preferred stock, in either case, by August 27, 2004 and (v) if, on any date occurring on or after May 27, 2007, the Parent’s common stock
shall fail to be listed on the NASD Over the Counter Bulletin Board, the NASDAQ SmallCap Market, NASDAQ National Market System, the American Stock Exchange or the New York Stock Exchange (each, a “Principal Market”) and the closing price
of the Parent’s common stock on such Principal Market shall be fail to be at least $.79 for five (5) of the trailing twenty (20) trading days prior to such date.” 
  
 4. The Company and the Parent hereby agree to, on or prior to September 22, 2004, file a post-effective amendment to its
Registration Statement (the “Post-Effective Amendment”) relating to the Certificate of Designations and the Securities Purchase Agreement, to ensure that a sufficient number of shares of Common Stock of the Company and the Parent are
registered under such Registration Statement, assuming (x) the full conversion of Series A Preferred Stock (after giving effect to the adjustments to the Fixed Conversion Price as set forth in Section 1 above) and (y) the complete exercise of all
warrants issued to Laurus in connection with the issuance of the Series A Preferred Stock. 
  
 5. Laurus, the Company and the Parent hereby agree that as promptly as practicable following the declaration by the Securities and Exchange Commission that the Post-Effective Amendment is effective, Laurus shall
convert into Common Stock of the Company (x) dividends that have accrued prior to September 1, 2004 in connection with the Series A Preferred Stock in an aggregate amount of $66,972.22 (the “Accrued Dividend Amount”) and (y) a stated
amount of Series A Preferred Stock equal to $33,027.78. 
  
 6. The
Company shall promptly and in any event no later than 2 business days after the date hereof file an amendment to the Certificate of Designations of the Company in the form of Exhibit A hereto with the Secretary of State of the State of Delaware
reflecting the change to the Conversion Price referred to in Section 1 of this Amendment No. 1. 
  
 7. This Amendment No. 1 shall be effective as of the date hereof following the execution of same by each of the Company, the Parent and Laurus.

 8. There are no other amendments to the By-Laws or the Securities Purchase Agreement, and all of the
other forms, terms and provisions of the By-Laws and Securities Purchase Agreement shall remain in full force and effect. 
  
 9. The Company and the Parent hereby represent and warrants to Laurus that as of the date hereof all representation, warranties and covenants made by the
Company and the Parent in connection with the By-Laws and Securities Purchase Agreement are true correct and complete and all of Company’s and the Parent’s covenants requirements have been met. 
  
 10. This Amendment No. 1 shall be binding upon the parties hereto and their
respective successors and permitted assigns and shall inure to the benefit of and be enforceable by each of the parties hereto and its successors and permitted assigns. THIS AMENDMENT NO. 1 SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH AND
GOVERNED BY THE LAW OF THE STATE OF NEW YORK. This Amendment No. 1 may be executed in any number of counterparts, each of which shall be an original, but all of which shall constitute one instrument. 
  
 [REMAINDER OF PAGE INTENTIONALLY BLANK] 

 IN WITNESS WHEREOF, each of the Parent, the Company and Laurus has caused this Amendment No. 1 signed in its name
effective as of this 15th day of September, 2004. 
  
  

					
	VERTICAL HEALTH SOLUTIONS, INC.
			
	 	 	By:	 	/s/ STEPHEN WATTERS
	 	 	Name: Stephen Watters
	 	 	Title: CEO

  
  

					
	VERTICAL HEALTH VENTURES, INC.
			
	 	 	By:	 	/s/ STEPHEN WATTERS
	 	 	Name: Stephen Watters
	 	 	Title: CEO

  
  

					
	LAURUS MASTER FUND, LTD.
			
	 	 	By:	 	/s/ DAVID GRIN
	 	 	Name: David Grin
	 	 	Title: Fund Manager

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00072-of-00352.parquet"}]]